English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Baylor College of Medicine
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
BCM researcher awarded grant to advance new ways to prevent and treat Alzheimer's disease
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Annual health checklist for older adults shared by Baylor College of Medicine expert
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Researchers identify mechanism driving pediatric brain tumor development in Nature study
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Researchers identify hormone-driven growth in lethal pediatric brain tumor
+
Pharmaceuticals
Patient Daily
| Mar 24, 2026
Researchers identify new immune response mechanism with implications for cancer treatment
+
Pharmaceuticals
Patient Daily
| Mar 23, 2026
Dr. Thomas Coffman to deliver Baylor College of Medicine commencement address in May
+
Pharmaceuticals
Patient Daily
| Mar 20, 2026
Baylor College of Medicine celebrates Match Day as President Klotman prepares to retire
+
Pharmaceuticals
Patient Daily
| Mar 19, 2026
Researchers find early weaning shapes gut immune system for lifelong health
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. Y. Bailey
| Aug 7, 2026
PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
1
2
3
4
…
»
Last »